ETF Holdings Breakdown of CVAC

Stock Name	CureVac NV
Ticker	CVAC(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	NL0015436031

CVAC institutional holdings

The adjusted close for CVAC on 2025-11-11 was 5.28

The following institutional investment holdings of CVAC have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-11 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 144,615 USD 763,567 0.9% 5.28

2025-11-11 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 144,615 USD 763,567 0.9% 5.28

Total = 289,230 USD 1,527,134
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2025-11-11	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	144,615	USD 763,567 0.9%	5.28
2025-11-11	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	144,615	USD 763,567 0.9%	5.28
Total =	289,230	USD 1,527,134

News associated with CVAC

Zurcher Kantonalbank Zurich Cantonalbank Has $81,000 Holdings in CureVac N.V. (NASDAQ:CVAC): Zurcher Kantonalbank Zurich Cantonalbank grew its position in CureVac N.V. (NASDAQ:CVAC – Free Report) by 14.3% during the 1st quarter, HoldingsChannel.com reports. The firm owned 29,125 shares of the company’s stock after acquiring an additional 3,648 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in CureVac were worth $81,000 as of its most recent […] - 2025-08-11 05:32:52
CureVac N.V. (NASDAQ:CVAC) Shares Sold by Signaturefd LLC: Signaturefd LLC lowered its position in shares of CureVac N.V. (NASDAQ:CVAC – Free Report) by 13.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 31,431 shares of the company’s stock after selling 4,709 shares during the quarter. Signaturefd LLC’s holdings in CureVac […] - 2025-07-22 08:07:17
Greenleaf Trust Buys New Shares in CureVac N.V. (NASDAQ:CVAC): Greenleaf Trust bought a new stake in CureVac N.V. (NASDAQ:CVAC – Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 11,036 shares of the company’s stock, valued at approximately $31,000. Other hedge funds and other institutional investors have also […] - 2025-07-14 05:36:52
CureVac (NASDAQ:CVAC) Earns “Hold” Rating from Jefferies Financial Group: Jefferies Financial Group reiterated their hold rating on shares of CureVac (NASDAQ:CVAC – Free Report) in a report issued on Friday morning, Marketbeat Ratings reports. The brokerage currently has a $5.00 price target on the stock, down from their previous price target of $7.00. Several other brokerages have also issued reports on CVAC. JMP Securities […] - 2025-06-16 02:38:52
Validea Joel Greenblatt Strategy Daily Upgrade Report - 6/13/2025: The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.CUREVAC BV (CVAC) is a small-cap value stock in the Biotechnolog - 2025-06-13 06:35:45
Pre-Market Most Active for Jun 12, 2025 : TSLL, SQQQ, CVAC, TQQQ, BA, NVDA, TSLA, GME, BBAI, QBTS, JPM, HPP: The NASDAQ 100 Pre-Market Indicator is down -57.22 to 21,803.58. The total Pre-Market volume is currently 263,688,138 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is -0.49 at $12.29, with 18,586,836 - 2025-06-12 09:29:51
CureVac (NASDAQ:CVAC) Earns Market Outperform Rating from JMP Securities: CureVac (NASDAQ:CVAC – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by stock analysts at JMP Securities in a report issued on Wednesday,Benzinga reports. They currently have a $10.00 target price on the stock. JMP Securities’ price target suggests a potential upside of 115.98% from the stock’s current price. Separately, UBS Group reduced […] - 2025-05-30 02:38:46
Geode Capital Management LLC Increases Holdings in CureVac (NASDAQ:CVAC): Geode Capital Management LLC increased its position in shares of CureVac (NASDAQ:CVAC – Free Report) by 10.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 241,750 shares of the company’s stock after purchasing an additional 22,491 shares during the quarter. Geode Capital […] - 2025-05-02 05:00:49

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.